Cargando…

Coformulation of Broadly Neutralizing Antibodies 3BNC117 and PGT121: Analytical Challenges During Preformulation Characterization and Storage Stability Studies

In this study, we investigated analytical challenges associated with the formulation of 2 anti-HIV broadly neutralizing antibodies (bnAbs), 3BNC117 and PGT121, both separately at 100 mg/mL and together at 50 mg/mL each. The bnAb formulations were characterized for relative solubility and conformatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patel, Ashaben, Gupta, Vineet, Hickey, John, Nightlinger, Nancy S., Rogers, Richard S., Siska, Christine, Joshi, Sangeeta B., Seaman, Michael S., Volkin, David B., Kerwin, Bruce A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6269598/ https://www.ncbi.nlm.nih.gov/pubmed/30176252 http://dx.doi.org/10.1016/j.xphs.2018.08.012

Ejemplares similares

The Effects of Somatic Hypermutation on Neutralization and Binding in the PGT121 Family of Broadly Neutralizing HIV Antibodies
por: Sok, Devin, et al.
Publicado: (2013)

Correction: The Effects of Somatic Hypermutation on Neutralization and Binding in the PGT121 Family of Broadly Neutralizing HIV Antibodies
por: Sok, Devin, et al.
Publicado: (2013)

Protective efficacy of the anti-HIV broadly neutralizing antibody PGT121 in the context of semen exposure
por: Parsons, Matthew S., et al.
Publicado: (2021)

Anti-Drug Antibodies in Pigtailed Macaques Receiving HIV Broadly Neutralising Antibody PGT121
por: Lee, Wen Shi, et al.
Publicado: (2021)

A calculated risk: Evaluating HIV resistance to the broadly neutralising antibodies10-1074 and 3BNC117
por: Zacharopoulou, Panagiota, et al.
Publicado: (2022)

Preformulation Characterization and Stability Assessments of Secretory IgA Monoclonal Antibodies as Potential Candidates for Passive Immunization by Oral Administration
por: Hu, Yue, et al.
Publicado: (2020)

Protection against SHIV Challenge by Subcutaneous Administration of the Plant-Derived PGT121 Broadly Neutralizing Antibody in Macaques
por: Rosenberg, Yvonne J., et al.
Publicado: (2016)

Therapeutic Efficacy of Vectored PGT121 Gene Delivery in HIV-1-Infected Humanized Mice
por: Badamchi-Zadeh, Alexander, et al.
Publicado: (2018)

Myomedin replicas of gp120 V3 loop glycan epitopes recognized by PGT121 and PGT126 antibodies as non-cognate antigens for stimulation of HIV-1 broadly neutralizing antibodies
por: Daniel Lišková, Veronika, et al.
Publicado: (2022)

Relationship between latent and rebound viruses in a clinical trial of anti–HIV-1 antibody 3BNC117
por: Cohen, Yehuda Z., et al.
Publicado: (2018)

Safety, pharmacokinetics, and immunogenicity of the combination of the broadly neutralizing anti-HIV-1 antibodies 3BNC117 and 10-1074 in healthy adults: A randomized, phase 1 study
por: Cohen, Yehuda Z., et al.
Publicado: (2019)

Preformulation Studies on Piperlongumine
por: Aodah, Alhassan, et al.
Publicado: (2016)

Injectable Coformulations in Diabetology
por: Kalra, Sanjay, et al.
Publicado: (2015)

Erratum to: Injectable Coformulations in Diabetology
por: Kalra, Sanjay, et al.
Publicado: (2015)

Stability Convergence in Antibody Coformulations
por: Zhang, Hongyu, et al.
Publicado: (2022)

Safety, pharmacokinetics and antiviral activity of PGT121, a broadly neutralizing monoclonal antibody against HIV-1: a randomized, placebo-controlled, phase 1 clinical trial
por: Stephenson, Kathryn E., et al.
Publicado: (2021)

Single-particle isomeric states in 121Pd and 117Ru
por: Lalkovski, S., et al.
Publicado: (2011)

Validation of a Triplex Pharmacokinetic Assay for Simultaneous Quantitation of HIV-1 Broadly Neutralizing Antibodies PGT121, PGDM1400, and VRC07-523-LS
por: Wesley, Martina S., et al.
Publicado: (2021)

Decreased Expression of BNC1 and BNC2 Is Associated with Genetic or Epigenetic Regulation in Hepatocellular Carcinoma
por: Wu, Yali, et al.
Publicado: (2016)

Broadly Neutralizing Antibody PGT121 Allosterically Modulates CD4 Binding via Recognition of the HIV-1 gp120 V3 Base and Multiple Surrounding Glycans
por: Julien, Jean-Philippe, et al.
Publicado: (2013)

A radiolabeled mAb 3BNC117 with copper-64: First round in favor for studying clearance of HIV reservoirs
por: León, Segundo R.
Publicado: (2021)

Analytical characterization of coformulated antibodies as combination therapy
por: Kim, Jun, et al.
Publicado: (2020)

Introduction of the YTE mutation into the non-immunogenic HIV bnAb PGT121 induces anti-drug antibodies in macaques
por: Rosenberg, Yvonne J., et al.
Publicado: (2019)

MAb PGT121 protects against mucosal SHIV challenge in macaques at concentrations corresponding to its highly potent in vitro neutralization capacity
por: Moldt, B, et al.
Publicado: (2012)

The decay of neutron deficient /sup 117,119m+g/, /sup 121m+g/Cs Low lying level structure in /sup 117,119,121/Xe nuclei
por: Genevey, J, et al.
Publicado: (1981)

Safety and Pharmacokinetics of Monoclonal Antibodies VRC07-523LS and PGT121 Administered Subcutaneously for Human Immunodeficiency Virus Prevention
por: Mahomed, Sharana, et al.
Publicado: (2022)

ESHRE PGT Consortium good practice recommendations for the organisation of PGT
por: Carvalho, Filipa, et al.
Publicado: (2020)

Stability enhancement in a mAb and Fab coformulation
por: Zhang, Hongyu, et al.
Publicado: (2020)

Mechanisms of escape from the PGT128 family of anti-HIV broadly neutralizing antibodies
por: Krumm, Stefanie A., et al.
Publicado: (2016)

ESHRE PGT Consortium data collection XXI: PGT analyses in 2018(†)
por: Spinella, F, et al.
Publicado: (2023)

Preformulation Characterization of Griffithsin, a Biopharmaceutical Candidate for HIV Prevention
por: Kramzer, Lindsay F., et al.
Publicado: (2021)

Pharmacotechnical and analytical preformulation studies for cannabidiol orodispersible tablets
por: Vlad, Robert-Alexandru, et al.
Publicado: (2021)

PGT or ICSI? The impression of NGS-based PGT outcomes in nonmosaic Klinefelter syndrome
por: Tong, Jing, et al.
Publicado: (2021)

TLR7 agonist, N6-LS and PGT121 delayed viral rebound in SHIV-infected macaques after antiretroviral therapy interruption
por: Hsu, Denise C., et al.
Publicado: (2021)

Optimized NGS Approach for Detection of Aneuploidies and Mosaicism in PGT-A and Imbalances in PGT-SR
por: García-Pascual, Carmen M., et al.
Publicado: (2020)

Commentary on “PGT or ICSI? The impression of NGS-based PGT outcomes in nonmosaic Klinefelter syndrome”
por: Greco, Ermanno, et al.
Publicado: (2021)

Preformulation Studies for Generic Omeprazole Magnesium Enteric Coated Tablets
por: Migoha, C. O., et al.
Publicado: (2015)

Lipid nanostructures for antioxidant delivery: a comparative preformulation study
por: Esposito, Elisabetta, et al.
Publicado: (2019)

Design of Nanotechnological Carriers for Ocular Delivery of Mangiferin: Preformulation Study
por: Santonocito, Debora, et al.
Publicado: (2022)

ESHRE PGT Consortium data collection XIX–XX: PGT analyses from 2016 to 2017(†)
por: van Montfoort, A, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_aa00os168nuscm07bplhq1vlb6